Frontiers in Cardiovascular Medicine
Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis
Cohort study of 185 peopleInterventions
- SGLT2 inhibitors
- Heart failure with preserved ejection fraction
- GDF-15
- Left ventricular global longitudinal strain
- NT-proBNP
- Humans
The paper
Huaian First People’s Hospital
Frontiers in Cardiovascular Medicine, 21 Jul 2026
